Paper36727249
[Sero-epidemiological characteristics of the hepatitis D virus infection among hepatitis B virus infected-patients at a single center in Xinjiang region].
Zheng RJ and 5 others. Zhonghua Gan Zang Bing Za Zhi, 2022. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. [Sero-epidemiological characteristics of the hepatitis D virus infection among hepatitis B virus infected-patients at a single center in Xinjiang region]. Papers, record 36727249. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36727249
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- [Sero-epidemiological characteristics of the hepatitis D virus infection among hepatitis B virus infected-patients at a single center in Xinjiang region].
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hepatitis B | Major topic |
| Hepatitis D | Major topic |
| Humans | |
| Biomarkers | |
| Cross-Sectional Studies | |
| Hematologic Tests | |
| Hepatitis Antibodies | |
| Hepatitis B Surface Antigens | |
| Hepatitis B virus | |
| Hepatitis B, Chronic | |
| Hepatitis Delta Virus | |
| China | |
| Viral Load | |
| Hepatitis Antigens | |
| Seroepidemiologic Studies | |
| RNA, Viral |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82060115 | National Natural Science Foundation of China | PubMed |
Source PubMed
References14
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35061846 | Hepatitis B, C and D virus infections and risk of hepatocellular carcinoma in Africa: A meta-analysis including sensitivity analyses for studies comparable for confounders. | PLoS One | 2022 | https://conductscience.org/library/papers/35061846 | PubMed |
| 2 | 35312737 | The kinesin KIF4 mediates HBV/HDV entry through the regulation of surface NTCP localization and can be targeted by RXR agonists in vitro. | PLoS Pathog | 2022 | https://conductscience.org/library/papers/35312737 | PubMed |
| 3 | 30228220 | Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis. | Gut | 2019 | https://conductscience.org/library/papers/30228220 | PubMed |
| 4 | 34696341 | Hepatitis D Review: Challenges for the Resource-Poor Setting. | Viruses | 2021 | https://conductscience.org/library/papers/34696341 | PubMed |
| 5 | 33484770 | The changing context of hepatitis D. | J Hepatol | 2021 | https://conductscience.org/library/papers/33484770 | PubMed |
| 6 | 34578380 | HDV Seroprevalence in HBsAg-Positive Patients in China Occurs in Hotspots and Is Not Associated with HCV Mono-Infection. | Viruses | 2021 | https://conductscience.org/library/papers/34578380 | PubMed |
| 7 | 31778167 | Estimating the Global Prevalence, Disease Progression, and Clinical Outcome of Hepatitis Delta Virus Infection. | J Infect Dis | 2020 | https://conductscience.org/library/papers/31778167 | PubMed |
| 8 | 32077599 | New epidemiology of hepatitis delta. | Liver Int | 2020 | https://conductscience.org/library/papers/32077599 | PubMed |
| 9 | 11242133 | Clinical characteristics of the patients with hepatitis B combining hepatitis D infection. | Zhonghua Gan Zang Bing Za Zhi | 2001 | https://conductscience.org/library/papers/11242133 | PubMed |
| 10 | 22246830 | Development of a hepatitis delta virus antibody assay for study of the prevalence of HDV among individuals infected with hepatitis B virus in China. | J Med Virol | 2012 | https://conductscience.org/library/papers/22246830 | PubMed |
| 11 | 32335166 | The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis. | J Hepatol | 2020 | https://conductscience.org/library/papers/32335166 | PubMed |
| 12 | 32151618 | Chronic hepatitis D and hepatocellular carcinoma: A systematic review and meta-analysis of observational studies. | J Hepatol | 2020 | https://conductscience.org/library/papers/32151618 | PubMed |
| 13 | 75123 | Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. | Gut | 1977 | https://conductscience.org/library/papers/75123 | PubMed |
| 14 | 34717740 | Hepatitis D: challenges in the estimation of true prevalence and laboratory diagnosis. | Gut Pathog | 2021 | https://conductscience.org/library/papers/34717740 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41372094 | [Analysis of the prevalence status and clinical characteristics of the hepatitis D virus in the Xinjiang region]. | Zhonghua Gan Zang Bing Za Zhi | 2025 | https://conductscience.org/library/papers/41372094 | PubMed |
| 39528333 | [Current status of diagnosis and treatment and progress in drug research and development for hepatitis D]. | Zhonghua Gan Zang Bing Za Zhi | 2024 | https://conductscience.org/library/papers/39528333 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36727249
GET https://conductscience.org/api/papers/v1/36727249/authors